Osteoporosis after combined use of a neuroleptic and antidepressants

Pharmacy World and Science

Volumn 30, Issue 5, 2008, Pages 613-616

  Laekeman, Gert ^a   Zwaenepoel, Lieven ^b   Reyntens, Johan ^c   De Vos, Marc ^a   Casteels, Minne ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Psychiatric Hospital St Jan ^*

^c Psychiatric Hospital   (Belgium)

Author keywords

Antidepressants; Antipsychotics; BMD; Osteoporosis; Prolactin; Rib fracture

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; FLUOXETINE; LORAZEPAM; NEUROLEPTIC AGENT; PAROXETINE; PROLACTIN; RISPERIDONE; SERTRALINE; TRAZODONE; VENLAFAXINE;

ADULT; ARTICLE; BONE DENSITY; CASE REPORT; DISEASE SEVERITY; DRUG MECHANISM; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HOSPITAL ADMISSION; HUMAN; MONOTHERAPY; OSTEOPOROSIS; PROBABILITY; PROLACTIN BLOOD LEVEL; RIB FRACTURE;

ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; DRUG INTERACTIONS; FEMALE; HUMANS; LORAZEPAM; MIDDLE AGED; OSTEOPOROSIS; PROLACTIN; RIB FRACTURES; RISPERIDONE; SERTRALINE;

EID: 52549085920     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-008-9231-6     Document Type: Article

References (16)

1. PJ Goodnick T Chaudry J Artadi S Arcey 2000 Women's issues in mood disorders Expert Opin Pharmacother. 1 903 16
2. U Halbreich N Rojansky S Palter M Hreshchyshyn J Kreeger Y Bakhai R Rosan 1995 Decrease bone mineral density in medicated psychiatric patients Psychosomstic Med 57 485 491
3. M Fric G Laux 2003 Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics Psychiatr Praxis 30 (Suppl. 2) S97 101
4. RC Love MW Nelson 2000 Pharmacology and clinical experience with risperdone Expert Opin Pharmacother. 1 1441 1453
5. Baxter K. Stockley's drug interactions. Pharmaceutical Press: London; 2008. p. 766-767.
6. JD Amsterdam F Garcia-Espana D Goodman M Hooper M Hornig-Rohan 1997 Breast enlargement during chronic antidepressant therapy J Affect Disord 46 151 6
7. J Morrison RA Remick M Leung KJ Wrixon RA Bebb 2001 Galactorrhea induced by paroxetine Can J Psychiatry 46 88 9
8. K Otani N Yasui S Kaneko M Ishida T Ohkubo T Osanai 1995 Trazodone treatment increases plasma prolactin concentrations in depressed patients Int Clin Psychopharmacol. 10 2 115 7
9. G Copinschi A Van Onderbergen M L'Hermite-Baleriaux M Szyper A Caufriez D Bosson 1990 Effects of the short-acting benzodiazepine triazolam, taken at bedtime, on circadian and sleep-related hormonal profiles in normal men Sleep 13 232 44
10. M Kopecek M Bares J Horacek P Mohr 2006 Low-dose risperidone augmentation of antidepressants or anxiolytics is associated with hyperprolactinemia. Neuro Endocrinol Lett. 27 6 803 6
11. MG Scordo E Spina G Facciolà A Avenoso I Johansson ML Dahl 1999 Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone Psychopharmacology 147 3 300 5
12. L Wang AP Zhang C Fang J Du JF Gu SY Qin GY Feng XW Li QH Xing L He 2007 Serum prolactin levels, plasma risperidone levels, polymorphism of cytochrome P450 2D6 and clinical response in patients with schizophrenia J Psychopharmacol 21 8 837 42
13. F Eskandari PE Martinez S Torvik TM Phillips E Sternberg S Mistry 2007 Low bone mass in premenopausal women with depression Arch Intern Med. 167 2329 2336
14. M Bilici H Cakirbay M Guler M Tosun M Ulgen U Tan 2002 Classical and atypical neuroleptics, and bone mineral density, in patients with schizophrenia Int J Neurosci. 112 817 28
15. CA Naranjo U Busto EM Sellers P Sandor I Ruiz EA Roberts 1981 A method for estimating the probability of adverse drug reactions Clin Pharmacol Ther. 30 239 45
16. Shakir SAW, Layton D. Causal application in pharmacovigilance and pharmacoepidemiology. Drug Saf. 2002;25 467-471.